In-silico trial of intracranial flow diverters replicates and expands insights from conventional clinical trials
In-silico trials rely on virtual populations and interventions simulated using patient-specific models and may offer a solution to lower costs. Here, the authors present the flow diverter performance assessment in-silico trial, which models the treatment of intracranial aneurysms with a flow-diverti...
Guardado en:
Autores principales: | Ali Sarrami-Foroushani, Toni Lassila, Michael MacRaild, Joshua Asquith, Kit C. B. Roes, James V. Byrne, Alejandro F. Frangi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2e882a4a293141e88a26a43c0ba14cb2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Hemodynamic analysis for endovascular treatment in small unruptured intracranial aneurysms: a matched comparison study of flow diverter versus LVIS
por: Jian Liu, et al.
Publicado: (2021) -
In Silico Model Estimates the Clinical Trial Outcome of Cancer Vaccines
por: Orsolya Lőrincz, et al.
Publicado: (2021) -
In silico trial of baroreflex activation therapy for the treatment of obesity-induced hypertension.
por: John S Clemmer, et al.
Publicado: (2021) -
In silico trial of baroreflex activation therapy for the treatment of obesity-induced hypertension
por: John S. Clemmer, et al.
Publicado: (2021) -
Simulated trials: in silico approach adds depth and nuance to the RCT gold-standard
por: Leia Wedlund, et al.
Publicado: (2021)